今日の臨床サポート

肝腫大

関連論文:
img  5:  Japanese case of Budd-Chiari syndrome due to hepatic vein thrombosis successfully treated with liver transplantation.
 
著者: Tomohiro Iwasaki, Hirokazu Kawai, Koushi Oseki, Tadayuki Togashi, Kazuhiko Shioji, Satoshi Yamamoto, Yoshinobu Sato, Kenji Suzuki, Ken Toba, Minoru Nomoto, Katsuyoshi Hatakeyama, Yutaka Aoyagi
雑誌名: Hepatol Res. 2012 Feb;42(2):213-8. doi: 10.1111/j.1872-034X.2011.00913.x.
Abstract/Text A 22-year-old Japanese woman was found to have severe esophageal varices and then suffered from hepatic encephalopathy. She was diagnosed with Budd-Chiari syndrome (BCS) due to hepatic vein (HV) thrombosis accompanied by portal vein thrombosis without inferior vena cava (IVC) obstruction. Latent myeloproliferative neoplasm (MPN) lacking the JAK2-V617F mutation was considered to be the underlying disease. Liver transplantation was strikingly effective for treating the clinical symptoms attributable to portal hypertension. Although thrombosis of the internal jugular vein occurred due to thrombocythemia, which manifested after transplantation despite anticoagulation therapy with warfarin, the thrombus immediately disappeared with the addition of aspirin. Neither thrombosis nor BCS has recurred in more than 4 years since the amelioration of the last thrombotic event, and post-transplant immunosuppression with tacrolimus has not accelerated the progression of MPN. In Japan, IVC obstruction, which was a predominant type of BCS, is suggested to have decreased in incidence with recent improvements in hygiene. The precise diagnosis of BCS and causative underlying diseases should be made with attention to the current trend of the disease spectrum, which fluctuates with environmental sanitation levels. Because the stepwise strategy, including liver transplantation, has been proven effective for patients with pure HV obstruction in Western countries, this strategy should also be validated for utilization in Japan and in developing countries where HV obstruction potentially predominates.

© 2011 The Japan Society of Hepatology.
PMID 22248193  Hepatol Res. 2012 Feb;42(2):213-8. doi: 10.1111/j.1872-034X.2011.00913.x.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから